Skip to main content
. 2023 Nov 7;9(11):e21875. doi: 10.1016/j.heliyon.2023.e21875

Table 4.

Association between MI incidence and Li, Zn, TAC, and biochemical parameters by quartiles.

Variable Crude
Adjusted
B OR CI-95 % P-value B OR CI-95 % P-value
Li (ng/mL) −0.007 0.993 0.99 to 0.996 <0.001 −0.007 0.994 0.99 to 0.997 <0.001
Q1(<98) Ref
Q2 (98154) −0.829 0.436 0.177 to 1.079 0.072 −0.93 0.395 0.151 to 1.032 0.058
Q3 (154212) −1.54 0.213 0.9 to 0.502 <0.001 −1.69 0.184 0.073 to 0.463 <0.001
Q4(>212)
−1.83
0.16
0.068 to 0.378
<0.001
−1.66
0.189
0.076 to 0.471
<0.001
Zn (μg/ml) 1.36 3.91 2.13 to 7.16 <0.001 1.11 3.03 1.59 to 5.76 0.001
Q1(<1348) Ref
Q2(13481810) −0.1 0.905 0.441 to 1.85 0.786 −0.003 0.997 0.485 to 2.17 0.994
Q3(18102369) 2.02 7.53 2.94 to 19.30 <0.001 1.60 4.96 1.83 to 13.44 0.002
Q4(>2369)
2.05
7.83
3.06 to 20.03
<0.001
1.79
6.01
2.22 to 16.23
<0.001
NO (μM) 0.296 1.34 1.23 to 1.46 <0.001 0.293 1.34 1.22 to 1.47 <0.001
Q1 (<15.75) Ref
Q2 (15.7518.11) −0.032 0.969 0.488 to 1.92 0.923 −0.083 0.92 0.436 to 1.94 0.824
Q3 (18.1124.42) 0.949 2.58 1.24 to 5.37 0.011 0.996 2.7 1.2 to 6.05 0.015
Q4(>24.42)
2.55
12.89
2.5 to 66.31
0.002
2.4
11.02
2.21 to 54.79
0.003
TAC (μM Fe2+) −0.021 0.979 0.971 to 0.986 <0.001 0.22 0.979 0.97 to 987 <0.001
Q1(<269.3) Ref
Q2(269.3303.11) −2.42 0.89 0.11 to 0.72 0.023 −2.4 0.9 0.11 to 0.755 0.026
Q3(303.11341.58) −3.67 0.25 0.003 to 0.197 <0.001 −3.95 0.19 0.002 to 0.163 <0.001
Q4(>341.58)
−4.02
0.18
0.002 to 0.138
<0.011
−4.14
0.16
0.002 to 0.130
<0.001
TC (mg/dl) 0.01 1.01 1.004 to 1.017 0.001 0.017 1.017 1.009 to 1.025 <0.001
Q1(<125) Ref
Q2(125151) 0.281 1.32 0.65 to 2.67 0.433 0.499 1.64 0.74 to 3.64 0.217
Q3(151181.1) 0.866 2.37 1.09 to 5.16 0.029 1.14 3.14 1.31 to 7.5 0.01
Q4(>181.1)
1.033
2.81
1.30 to 6.05
0.008
1.56
4.8
1.98 to 11.61
<0.001
TG (mg/dl) 0.005 1.005 1.001 to 1.005 0.019 0.009 1.009 1.004 to 1.014 0.001
Q1(<91) Ref
Q2(91131) −0.373 0.688 0.33 to 1.43 0.32 0.078 1.08 0.467 to 2.5 0.856
Q3(131196) −0.597 0.551 0.265 to 1.14 0.11 −0.014 0.986 0.417 to 2.33 0.975
Q4(>196)
0.688
1.99
0.858 to 4.61
0.109
1.41
4.12
1.55 to 10.61
0.004
LDL-C (mg/dl) 0.011 1.012 1 to 1.019 0.004 0.017 1.018 1 to 1.027 <0.001
Q1 (<62.57) Ref
Q2 (62.5788.1) 0.629 1.87 0.909 to 3.87 0.089 1.071 2.91 1.25 to 6.78 0.013
Q3 (88.1116.92) 0.703 2.02 0.97 to 4.19 0.059 1.343 3.81 1.63 to 8.96 0.002
Q4 (>116.92)
1.09
2.98
1.37 to 6.47
0.006
1.786
5.96
2.39 to 14.89
<0.001
HDL-C (mg/dl) −0.033 0.967 0.944 to 0.93 0.013 −0.036 0.964 0.936 to 0.99 0.019
Q1(<24) Ref
Q2(2432) −0.572 0.562 0.234 to 1.36 0.203 −0.795 0.451 0.16 to 1.029 0.131
Q3(3240.9) −0.775 0.461 0.193 to 1.09 0.081 −0.78 0.458 0.177 to 1.19 0.109
Q4(>40.9)
−1.05
0.348
0.147 to 0.82
0.017
−1.37
0.252
0.095 to 0.68
0.007
hs-CRP (mg/l) 0.04 1.04 1.01 to 1.07 0.007 0.044 1.045 1.01 to 1.07 0.008
Q1(<2.5) Ref
Q2(2.55) 0.47 1.6 0.765 to 3.34 0.212 0.845 2.32 1.02 to 5.31 0.045
Q3(510.3) 0.147 1.15 0.533 to 2.42 0.697 0.363 1.43 0.619 to 3.33 0.399
Q4(>10.3) 0.798 2.22 1.01 to 4.86 0.046 1.105 3.01 1.26 to 7.21 0.013

A logistic regression test was performed to evaluate the severity of the MI.

The data were presented crude and adjusted with age, BMI, gender, Residence, and Smoking. In addition, the data is expressed in quarters, with quarter1 being compared to other quarters as a reference.

Abbreviation; Q: Quartile; OR: Odds ratio, Ref: Reference, CI-95 %: 95 % confidence interval, Li: Lithium, Zn: Zinc, NO: Nitric Oxide, TAC: Total antioxidant capacity, TC: Total cholesterol, TG: triglyceride, LDL-c: Low-density lipoprotein cholesterol, HDL-c: High-density lipoprotein cholesterol, hs-CRP: High-sensitivity C-reactive Protein.